An observational study in Heart Failure, sponsored by Thomas Jefferson University. Withdrawn at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2015-02-06.
Sponsored by Thomas Jefferson University · Observational
A research study to determine if heart failure can be medically managed using data collected from cardiac monitoring devices
5,701 studies on the registry are indexed under Heart Failure; 1,220 are open to participants now.
Browse Heart Failure studies →Thomas Jefferson University is the lead sponsor of 384 studies on the registry; 71 are open to participants now.
Of its 44 completed or terminated interventional studies of FDA-regulated products, 20 (45%) have results posted.
Counted across the registry records on this site, refreshed daily.
hospital inpatients
Exclusion Criteria:
A single cohort group of heart failure patients with already implanted Optivol® capable devices who are discharged home from the hospital
Physician Use of Cardiac Compass Reports to Determine HF Treatment Decisions
Assessment will be completed at time of enrollment and days 3 to 7, 14 to 21, 30 and 90 post discharge.
Time frame: 90 days from enrollment
Heart Failure Clinical Events
Track HF re-admissions and other clinical encounters between 30 and 90 days post discharge for HF.
Time frame: 90 days from enrollment
Assess Patient-Reported Quality of Life
Assess the association between the use of Cardiac Compass Report and OptiVol® and improved HF patient quality of life at both time points (30 and 90 days post discharge) utilizing the Kansas City Cardiomyopathy Questionnaire (KCCQ)
Time frame: 90 days from enrollment
This study is withdrawn, as verified in Feb 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Thomas Jefferson University